StopDown
Theranautilus logo
Award · 18 September 2026TheranautilusMagnetically controlled nanorobot medical technologytheranautilus.com ↗

Theranautilus wins Top Innovator at ET Startup Awards

By · Editor ·

earlyFounded 2020
  • Theranautilus develops magnetically controlled nanorobots designed for targeted drug delivery, diagnostics, and medical treatments
  • The company won the Top Innovator award at the 2026 ET Startup Awards and is preparing for human dental trials
  • The startup plans to commercialize its oral health solution within two years and its oncology technology within five years

What happened

  • Theranautilus received the Top Innovator title at the ET Startup Awards 2026.
  • The company will begin human trials for its dental nanorobot technology between November and December 2026.
  • The initial phase of the trial will involve approximately 30 patients.
  • A larger multicentric trial involving 300 patients will follow the first phase.
  • Human testing follows successful mice trials and official CDSCO (Central Drugs Standard Control Organisation) permission.
  • The company aims to launch its oral health solution commercially within two years.

Why it matters

  • The startup was previously recognized as one of India's Top 10 innovative startups by the government.
  • It has received several honors including the Presidential National Award and the Tata Transformation Prize.
  • The company's technology has been showcased to international leaders and the Prime Minister of India.

The business

  • The company builds magnetically controlled nanorobots for medical applications.
  • Its core pillars are Reach, Diagnose, and Treat at the microscale level.
  • The lead product for oncology is named CalBot.
  • Dental applications include treating dentin hypersensitivity and managing biofilms.
  • Oncology applications focus on the brain and peritoneal cavity.
  • The technology is currently at TRL-5 (Technology Readiness Level 5).

The founders

Peddi Shanmukh Srinivas

Cofounder & CEO
  • Serves as the Chief Executive Officer of the company.
  • Leads the strategic development of the nanorobotics platform.

In numbers

1 Billion+Addressable patients · 2026

What happens next

  • Commercialize oral health technology within two years.
  • Commercialize oncology technology within four to five years.

Words to know

CDSCO
The national regulatory body for Indian pharmaceuticals and medical devices.
Multicentric trial
A clinical trial conducted at more than one medical center or site.
TRL-5
Technology Readiness Level 5 indicates the technology has been validated in a relevant environment.

The numbers around it

Healthcare & Life Sciences in September 2026: 11 rounds with a disclosed amount, $114 million in all; the biggest was Ultrahuman ($70 mn). Every sector this year →

Read it as a card in the app

Terms in this story

  • Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.

All startup news on 18 September 2026 →

Is this Theranautilus? Get your “Featured on StopDown” badge →